These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4314431)

  • 21. Serologic response and antibody-titer decay in adults with pertussis.
    Heininger U; Cherry JD; Stehr K
    Clin Infect Dis; 2004 Feb; 38(4):591-4. PubMed ID: 14765356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age.
    Hendrikx LH; de Rond LG; Oztürk K; Veenhoven RH; Sanders EA; Berbers GA; Buisman AM
    Vaccine; 2011 Aug; 29(34):5725-30. PubMed ID: 21669247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1.
    Feunou PF; Kammoun H; Debrie AS; Mielcarek N; Locht C
    Vaccine; 2010 Oct; 28(43):7047-53. PubMed ID: 20708998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective antigens of Bordetella pertussis mouse-protection test against intracerebral and aerosol challenge of B. pertussis.
    Sato H; Sato Y
    Dev Biol Stand; 1985; 61():461-7. PubMed ID: 2872127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cellular immune response to Bordetella pertussis in two children with whooping cough.
    Hafler JP; Pohl-Koppe A
    Eur J Med Res; 1998 Nov; 3(11):523-6. PubMed ID: 9810032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of maternal antibody on the serologic response and the incidence of adverse reactions after primary immunization with acellular and whole-cell pertussis vaccines combined with diphtheria and tetanus toxoids.
    Englund JA; Anderson EL; Reed GF; Decker MD; Edwards KM; Pichichero ME; Steinhoff MC; Rennels MB; Deforest A; Meade BD
    Pediatrics; 1995 Sep; 96(3 Pt 2):580-4. PubMed ID: 7659480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An investigation into the cause of the 1983 whooping cough epidemic in the Netherlands.
    van Gent M; de Greeff SC; van der Heide HG; Mooi FR
    Vaccine; 2009 Mar; 27(13):1898-903. PubMed ID: 19368769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Letter: Protective activity of whooping-cough convalescent serum and serum-IgA level in mice infected with Bordetella pertussis.
    Pittman M
    Lancet; 1976 Jul; 2(7977):156. PubMed ID: 59233
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunological surveys of antibodies against B. pertussis and B. parapertussis in some African and Asian countries.
    Maixnerova M; Buriánová B; Teplý V; Pecenka J; Serý V; Jezek Z
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(2):201-11. PubMed ID: 231624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Whooping cough in Finland 1920-1978. Statistical and epidemiological studies.
    Huovila R
    Acta Paediatr Scand Suppl; 1982; 298():1-29. PubMed ID: 6305107
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antigens of Bordetella pertussis and their repercussion in immunization programs against whooping cough].
    Casal Lombos J
    Rev Sanid Hig Publica (Madr); 1971 May; 45(5):575-87. PubMed ID: 4330706
    [No Abstract]   [Full Text] [Related]  

  • 32. [Passive and active immunity in pertussis of infants].
    Pstragowska W
    Pediatr Pol; 1966 Apr; 41(4):415-20. PubMed ID: 5940885
    [No Abstract]   [Full Text] [Related]  

  • 33. Seroprevalence of IgG antibodies against Bordetella pertussis in healthy individuals aged 4-24 years in Turkey.
    Cevik M; Beyazova U; Aral AL; Duyan Camurdan A; Ozkan S; Sahin F; Aybay C
    Clin Microbiol Infect; 2008 Apr; 14(4):388-90. PubMed ID: 18190581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody responses in adult and neonatal BALB/c mice to immunization with novel Bordetella pertussis vaccine formulations.
    Gracia A; Polewicz M; Halperin SA; Hancock RE; Potter AA; Babiuk LA; Gerdts V
    Vaccine; 2011 Feb; 29(8):1595-604. PubMed ID: 21215343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laboratory correlates of protection and protective immunity to Bordetella pertussis.
    Shahin RD; Mink C; Wiedermann BL; Meade BD
    Adv Exp Med Biol; 1992; 327():287-92. PubMed ID: 1295347
    [No Abstract]   [Full Text] [Related]  

  • 36. Examination of similarities between diphtheria and pertussis and their toxoids provide insight into vaccine-induced protection to Bordetella pertussis.
    Schneerson R; Robbins JB; Taranger J; Lagerård T; Trollfors B
    Dev Biol Stand; 1997; 89():321-6. PubMed ID: 9272366
    [No Abstract]   [Full Text] [Related]  

  • 37. The antibody activities of 19S and 7S fractions from rabbit antisera to Bordetella pertussis.
    Dolby JM; Dolby DE
    Immunology; 1969 Jun; 16(6):737-47. PubMed ID: 4306784
    [No Abstract]   [Full Text] [Related]  

  • 38. [Acellular pertussis vaccine].
    Wiedermann G; Ambrosch F; Vanura H
    Wien Med Wochenschr; 1991; 141(12):270-2. PubMed ID: 1949820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective activities of "Bordetella pertussis" Tn5 mutants in mice.
    Olander RM; Muotiala A; Parviainen T; Runeberg-Nyman K
    Ann Sclavo Collana Monogr; 1986; 3(1-2):329-35. PubMed ID: 2892513
    [No Abstract]   [Full Text] [Related]  

  • 40. Experimental pertussis infection in the rabbit: similarities with infection in primates.
    Preston NW; Timewell RM; Carter EJ
    J Infect; 1980 Sep; 2(3):227-35. PubMed ID: 6309966
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.